New exclusive representation of Bioportugal in the molecular diagnostic area with exclusive multiplex PCR kits in real time for virus detection, bacteria and in Gastrointestinal infections resistance: Mobidiag.
Mobidiag is a biotechnology company specializing in developing and marketing novel, innovative solutions for molecular diagnostics of infectious diseases. Established in 2000, Mobidiag has served the European clinical diagnostics market with its multiplex Prove-it™ product family since 2008. In 2013, Mobidiag merged with a diagnostic platform developer Genewave and a stool-based clinical assay development company Amplidiag, complementing their abilities in developing and offering industry-leading diagnostic solutions and solidifying their position in the field of molecular diagnostics.
Para saber mais visite o site: www.mobidiag.com